Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

OBJECTIVE: Most individuals with type 2 diabetes also have obesity, and treatment with some diabetes medications, including insulin, can cause further weight gain. No approved chronic weight management medications have been prospectively investigated in individuals with overweight or obesity and ins...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Garvey, W. Timothy, Birkenfeld, Andreas L., Dicker, Dror, Mingrone, Geltrude, Pedersen, Sue D., Satylganova, Altynai, Skovgaard, Dorthe, Sugimoto, Danny, Jensen, Camilla, Mosenzon, Ofri
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2020
Assuntos:
Emerging Therapies: Drugs and Regimens
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171937/
https://ncbi.nlm.nih.gov/pubmed/32139381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados